DJ Sativa Investments PLC George Botanicals launches CBD balm and MCT oils
RNS Number : 6712I
Sativa Investments PLC
28 November 2018
Press Release 28(th) November 2018
Sativa Investments PLC investment George Botanicals
launches cannabidiol (CBD) balm and flavoured MCT oils
("George Botanicals" or "GB" or "the Company")
Sativa Investments PLC's investee business, UK CBD manufacturer and distributor George Botanicals, has expanded its range of CBD products with the launch of a CBD balm, along with a range of MCT (medium-chain triglycerides) oils in raspberry, chocolate & hazelnut, and black-forest gateau flavours which complement drinks including coffee, tea and soft drinks.
Demand for CBD products is growing fast as consumers seek the well-being effects of CBD which are believed to include relief for pain and anxiety. The human body is constantly producing cannabinoids, and these natural CBD products are thought to boost internal cannabinoids in a similar way as vitamin supplements. CBD products are manufactured using extracts from the flowers and leaves of the hemp plant and the products have no known adverse side effects.
The George Botanicals range, which extends to drops, capsules, edible gels and vapes, is sourced to be organic, vegan-friendly and gluten-free, with all merchandise tested at an on-site laboratory and fully compliant with industry standards.
The balm contains one per cent of CBD and is made primarily of organic ingredients including shea butter, cacao butter and vitamin E. It can be applied easily direct to skin to address problems such as rashes and joint aches including arthritis.
The 10ml MCT oils have a five per cent concentration of CBD and derive from coconut oil, making it easy to mix with beverages. Already very commonplace in the United States, MCT oils can also be placed under the tongue for an instant fruity flavour and fast absorption into the body.
George Thomas, Managing Director of George Botanicals, said: "The team at George Botanicals is very excited to launch the balm and MCT oils as we enhance our product offering to cater for the needs of every customer type, with a strong focus on high quality and customer satisfaction.
"CBD has become increasingly popular in the past few months as customers become aware of its associated health and well-being benefits. At George Botanicals, we always ensure we keep up with demand and trends by developing our products in different and innovative formats, which can be incorporated into our customers' daily routine."
300mg Balm RRP GBP24.99.
10ml MCT oil RRP GBP29.99.
Available from www.georgebotanicals.com, high street stores and independent retailers. Photographs available from Abchurch Communications (see below).
- Ends -
For further information please contact:
George Thomas Managing Director George Botanicals Ltd +44 (0) 1373 470 414 email@example.com Public Relations Abchurch Communications Julian Bosdet Alejandra Campuzano +44 (0) 20 7469 4634 Dylan Mark +44 (0) 20 7469 4633 Switchboard +44 (0) 20 7469 4630 www.abchurch-group.com
Notes to Editors
George Botanicals is an established UK manufacturer and distributor of high-quality organic and innovative CBD wellness products in a range of formats, including E-liquids, vapes, capsules, balms, edible gels and drops, which cater to the needs of the wellness sector as they are perceived to have healthcare benefits and improve well-being. These products come in different ranges of sizes and CBD strengths.
The Company's products are sold through its website, wholesale distributors and high street and small retailers. It is a wholly owned subsidiary of the UK's first medicinal cannabis investment vehicle, Sativa Investments PLC.
All of the Company's products are primarily organic, gluten-free and vegan-friendly and are carefully tested in the Company's onsite laboratory to ensure they are non-damaging, fully compliant and meet industry standards.
CBD is legal in the UK and across most of Europe and George Botanicals' products have no known side effects.
For more information on George Botanicals, please visit: www.georgebotanicals.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.
(END) Dow Jones Newswires
November 28, 2018 02:01 ET (07:01 GMT)